Literature DB >> 23078362

Performance of the fullPIERS model in predicting adverse maternal outcomes in pre-eclampsia using patient data from the PIERS (Pre-eclampsia Integrated Estimate of RiSk) cohort, collected on admission.

B Payne1, S Hodgson, J A Hutcheon, K S Joseph, J Li, T Lee, L A Magee, Z Qu, P von Dadelszen.   

Abstract

The fullPIERS (Pre-eclampsia Integrated Estimate of RiSk) model is a promising tool for the prediction of adverse outcomes in pre-eclampsia, developed using the worst values for predictor variables measured within 48 hours of admission. We reassessed the performance of fullPIERS using predictor variables obtained within 6 and 24 hours of admission, and found that the stratification capacity, calibration ability, and classification accuracy of the model remained high. The fullPIERS model is accurate as a rule-in test for adverse maternal outcome, with a likelihood ratio of 14.8 (95% CI 9.1-24.1) or 17.5 (95% CI 11.7-26.3) based on 6- and 24-hour data, respectively, for the women identified to be at highest risk (predicted probability ≥ 30%).
© 2012 The Authors BJOG An International Journal of Obstetrics and Gynaecology © 2012 RCOG.

Entities:  

Mesh:

Year:  2012        PMID: 23078362     DOI: 10.1111/j.1471-0528.2012.03496.x

Source DB:  PubMed          Journal:  BJOG        ISSN: 1470-0328            Impact factor:   6.531


  9 in total

1.  The prognostic utility of soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PIGF) biomarkers for predicting preeclampsia: a secondary analysis of data from the INSPIRE trial.

Authors:  Meron M Kifle; Prabin Dahal; Manu Vatish; Ana Sofia Cerdeira; Eric O Ohuma
Journal:  BMC Pregnancy Childbirth       Date:  2022-06-27       Impact factor: 3.105

2.  Prediction of Adverse Maternal Outcomes in Preeclampsia Using a Risk Prediction Model.

Authors:  Shruti Agrawal; Nandita Maitra
Journal:  J Obstet Gynaecol India       Date:  2015-11-11

Review 3.  Pre-eclampsia part 2: prediction, prevention and management.

Authors:  Tinnakorn Chaiworapongsa; Piya Chaemsaithong; Steven J Korzeniewski; Lami Yeo; Roberto Romero
Journal:  Nat Rev Nephrol       Date:  2014-07-08       Impact factor: 28.314

4.  Risk factors for adverse maternal and perinatal outcomes in women with preeclampsia: analysis of 1396 cases.

Authors:  Xun Li; Weishe Zhang; Jianhua Lin; Huai Liu; Zujing Yang; Yincheng Teng; Si Duan; Xinxiu Lin; Yingming Xie; Yuanqiu Li; Liangqun Xie; Qiaozhen Peng; Lu Xia
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-04-30       Impact factor: 3.738

Review 5.  Preventing deaths due to the hypertensive disorders of pregnancy.

Authors:  Peter von Dadelszen; Laura A Magee
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2016-06-28       Impact factor: 5.237

6.  Risk factors for eclampsia in pregnant women with preeclampsia and positive neurosensory signs.

Authors:  Houssam Rebahi; Megan Elizabeth Still; Yassine Faouzi; Ahmed Rhassane El Adib
Journal:  Turk J Obstet Gynecol       Date:  2019-01-09

7.  Effectiveness and safety of 1 vs 4 h blood pressure profile with clinical and laboratory assessment for the exclusion of gestational hypertension and pre-eclampsia: a retrospective study in a university affiliated maternity hospital.

Authors:  Elizabeth Anne McCarthy; Thomas A Carins; Yolanda Hannigan; Nadia Bardien; Alexis Shub; Susan P Walker
Journal:  BMJ Open       Date:  2015-11-18       Impact factor: 2.692

8.  Improved prediction of gestational hypertension by inclusion of placental growth factor and pregnancy associated plasma protein-a in a sample of Ghanaian women.

Authors:  Edward Antwi; Kerstin Klipstein-Grobusch; Joyce L Browne; Peter C Schielen; Kwadwo A Koram; Irene A Agyepong; Diederick E Grobbee
Journal:  Reprod Health       Date:  2018-03-27       Impact factor: 3.223

9.  The PRECISE (PREgnancy Care Integrating translational Science, Everywhere) Network's first protocol: deep phenotyping in three sub-Saharan African countries.

Authors:  Peter von Dadelszen; Meriel Flint-O'Kane; Lucilla Poston; Rachel Craik; Donna Russell; Rachel M Tribe; Umberto d'Alessandro; Anna Roca; Hawanatu Jah; Marleen Temmerman; Angela Koech Etyang; Esperança Sevene; Paulo Chin; Joy E Lawn; Hannah Blencowe; Jane Sandall; Tatiana T Salisbury; Benjamin Barratt; Andrew H Shennan; Prestige Tatenda Makanga; Laura A Magee
Journal:  Reprod Health       Date:  2020-04-30       Impact factor: 3.223

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.